Lithium

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Pharmacokinetic Divide (Acute vs. Chronic): The core driver of lithium toxicity manifestations depends strictly on whether the accumulation is acute or chronic.
• Acute Toxicity: Characterized by early, prominent gastrointestinal (GI) symptoms, whereas neurologic toxicity manifests late due to the time required for the drug to cross the blood-brain barrier and distribute into the central nervous system (CNS).
• Chronic Toxicity: Patients on maintenance therapy who develop decreased renal clearance accumulate lithium insidiously. In these cases, the cellular threshold in the CNS has already been breached. Therefore, neurologic findings (tremors, altered mental status, seizures) are the presenting signs, and GI symptoms are characteristically absent.
• Electrolyte Derangements: Lithium accumulation directly interferes with renal tubular concentrating ability and ion homeostasis, classically resulting in systemic alterations in sodium and calcium, most notably precipitating hypercalcemia and hypernatremia.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Initial Stabilization: Immediately protect the airway (especially if altered or seizing) and provide respiratory and hemodynamic support. Establish IV access and initiate continuous cardiac rhythm monitoring.
• Decontamination: Do not administer activated charcoal or whole bowel irrigation (WBI); neither is indicated in the routine management of acute or chronic lithium toxicity.
• Targeted Resuscitation (Renal Clearance):
• Intravenous Crystalloids: Aggressive IV fluid hydration with crystalloids is essential to enhance the renal excretion of lithium.
• Strict Contraindication: Diuretics are strictly contraindicated as they can worsen volume depletion and paradoxically decrease lithium clearance.
• Monitoring Parameters: Monitor serum lithium concentrations every 2 to 4 hours initially to determine the peak level and evaluate the trajectory until you observe two consecutive declining measurements.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• "Can't-Miss" Mimics:
• Withdrawal Syndromes: Alcohol or benzodiazepine withdrawal.
• Toxicologic Mimics: Sympathomimetic toxicity (cocaine, amphetamines) and Serotonin Syndrome.
• Medical Mimics: Acute neurologic events, early pregnancy, and intra-abdominal pathologies.
• Prioritized Diagnostic Workup:
• Serial Serum Lithium Levels: Normal therapeutic concentrations are 0.6 to 1.2 mEq/L. In acute overdoses, peak concentrations can be delayed well beyond 6 hours.
• Renal & Electrolyte Panel: Mandatory assessment of renal function (BUN/creatinine or GFR) and electrolytes, specifically looking for hypercalcemia and hypernatremia.
• Thyroid Function Tests: Obtain if there is clinical concern for lithium-induced thyroid dysfunction.
• Co-Ingestant Screen: Check acetaminophen and salicylate levels in all intentional acute ingestions.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The Toxic ECG Checklist:
• Obtain a baseline 12-lead ECG and initiate continuous cardiac monitoring on all patients with suspected lithium toxicity to evaluate for dysrhythmias and baseline intervals.
• While the provided text does not specify pathognomonic morphologic changes for lithium, the ECG is critical to screen for cardiotoxic co-ingestants (e.g., QRS widening from tricyclic antidepressants) and to monitor hemodynamic stability during resuscitation.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• Definitive Indications for Hemodialysis:
  The decision to initiate extracorporeal removal (hemodialysis) is driven by specific clinical and laboratory cutoffs:

1. Absolute Level: Acute or chronic toxicity with a serum lithium level > 5 mEq/L.
2. Severe Neurotoxicity: Presence of tremors, clonus, somnolence, altered mental status, or seizures—regardless of the serum lithium concentration.
3. Resuscitation Failure: Patients who are severely symptomatic and unable to tolerate crystalloid fluid resuscitation.
4. Renal Failure: Presence of significant renal impairment preventing natural clearance.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Pitfall: Attempting to forcefully diurese the patient or decontaminate the gut with charcoal.
• Critical Action: Board examiners mandate that you recognize diuretics, activated charcoal, and whole bowel irrigation are contraindicated or not indicated for lithium toxicity. Rely exclusively on IV crystalloid hydration and hemodialysis.
• Pitfall: Withholding hemodialysis because the lithium level has not reached 5 mEq/L.
• Critical Action: You must initiate emergent hemodialysis for any patient exhibiting signs of severe neurologic toxicity (e.g., clonus, seizures, profound AMS), regardless of what the serum concentration is.
• Pitfall: Misdiagnosing chronic lithium toxicity due to an absence of nausea and vomiting.
• Critical Action: Recognize that chronic lithium toxicity predominantly presents with insidious neurologic findings (tremors, hyperreflexia) and frequently lacks the early GI symptoms seen in acute overdoses.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzword: "Patient with bipolar disorder presents with new-onset tremor, clonus, and confusion; no vomiting." Exam Answer: Chronic lithium toxicity.
• Buzzword: "Lithium overdose + seizure." Exam Answer: Emergent hemodialysis (neurologic toxicity mandates dialysis regardless of the level).
• Distractor: An option suggests administering activated charcoal or furosemide (diuretic) to a patient with a lithium overdose. Correction: These are harmful traps. Charcoal does not bind lithium, and diuretics worsen toxicity. The correct answer will be IV crystalloid hydration.
• High-Yield Fact: Lithium toxicity frequently causes derangements in concentrating ability, leading to hypernatremia and hypercalcemia.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Rapid Differentiation: "The patient presents with tremors, hyperreflexia, and altered mental status. Given their history of lithium maintenance therapy, I am highly suspicious for chronic lithium toxicity, which famously presents with prominent neurotoxicity and an absence of gastrointestinal symptoms."
• The Medical Management: "I will immediately establish IV access, place the patient on a cardiac monitor, and initiate aggressive IV crystalloid hydration to optimize renal perfusion and lithium clearance. I am specifically avoiding diuretics and activated charcoal."
• The Hemodialysis Escalation: "Because this patient is exhibiting severe neurotoxicity with clonus and altered mental status, they meet absolute criteria for extracorporeal removal. I am consulting nephrology for emergent hemodialysis now, and I will not wait for the serum lithium level to result before making this consultation."